Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice.

Paolo Macor,Erika Secco,Nelly Mezzaroba,Sonia Zorzet,Paolo Durigutto,Tiziano Gaiotto,L. De Maso,Stefania Biffi,Chiara Garrovo,Sara Capolla,Claudio Tripodo,Valter Gattei,Roberto Marzari,Francesco Tedesco,Daniele Sblattero

Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice.

2015

Paolo Macor
Erika Secco
Nelly Mezzaroba
Sonia Zorzet
Paolo Durigutto
Tiziano Gaiotto
L. De Maso
Stefania Biffi
Chiara Garrovo
Sara Capolla
Claudio Tripodo
Valter Gattei
Roberto Marzari
Francesco Tedesco
Daniele Sblattero

Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice

Keywords:

Cancer research
Antibody
Fusion gene
Immunotherapy
Hematology
Stem cell
Antigen
Immunology
Leukemia
Complement system
Internal medicine
Biology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations